Cough, Cold and Allergy (Hay Fever) Remedies in Italy
Cough, cold and allergy (hay fever) remedies is set to see retail value sales fall in current terms in Italy in 2024. Remedies for coughs and colds suffered from the waning of the flu season in early 2024 compared to the previous season, although the incidence of influenza was extremely high, exceeding 14 million cases. The shortness of the flu season meant that by the end of January there was already a significant drop in sales of cough remedies, syrups, decongestants and sore throat products.
Euromonitor International's Cough, Cold and Allergy (Hay Fever) Remedies in Italy report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2019-2023, allowing you to identify the sectors driving growth. Forecasts to 2028 illustrate how the market is set to change.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report? * Get a detailed picture of the Cough, Cold and Allergy (Hay Fever) Remedies market; * Pinpoint growth sectors and identify factors driving change; * Understand the competitive environment, the market’s major players and leading brands; * Use five-year forecasts to assess how the market is predicted to develop.
Cough, Cold and Allergy (Hay Fever) Remedies in Italy
Euromonitor International
September 2024
List Of Contents And Tables
COUGH, COLD AND ALLERGY (HAY FEVER) REMEDIES IN ITALY
KEY DATA FINDINGS
2024 DEVELOPMENTS
Short flu season and early summer hinder cough and cold remedy sales
Nasal decongestants sees decline as disinvestment fuels shift to natural, isotonic options
Antihistamines sales surge due to early spring
PROSPECTS AND OPPORTUNITIES
Natural remedies on the rise as propolis and echinacea challenge standard cough and cold drugs
E-commerce requires engaging strategies for cough and cold remedies amidst scepticism and demand for speedy relief
Government renews free flu vaccination campaign for high-risk groups, while information on medicines containing pseudoephedrine is updated
CATEGORY DATA
Table 1 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2019-2024
Table 2 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2019-2024
Table 3 NBO Company Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2020-2024
Table 4 LBN Brand Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2021-2024
Table 5 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2024-2029
Table 6 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2024-2029
CONSUMER HEALTH IN ITALY
EXECUTIVE SUMMARY
Consumer health in 2024: The big picture
2024 key trends
Competitive landscape
Retailing developments
What next for consumer health?
MARKET INDICATORS
Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2019-2024
Table 8 Life Expectancy at Birth 2019-2024
MARKET DATA
Table 9 Sales of Consumer Health by Category: Value 2019-2024
Table 10 Sales of Consumer Health by Category: % Value Growth 2019-2024
Table 11 NBO Company Shares of Consumer Health: % Value 2020-2024
Table 12 LBN Brand Shares of Consumer Health: % Value 2021-2024
Table 13 Penetration of Private Label in Consumer Health by Category: % Value 2019-2024
Table 14 Distribution of Consumer Health by Format: % Value 2019-2024
Table 15 Distribution of Consumer Health by Format and Category: % Value 2024
Table 16 Forecast Sales of Consumer Health by Category: Value 2024-2029
Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2024-2029
APPENDIX
OTC registration and classification
Vitamins and dietary supplements registration and classification